PNC is a biomarker for anti-cancer drug development.

被引：0
|
作者：
Huang, S. [1 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Cell & Dev Biol, Chicago, IL USA
来源：
MOLECULAR BIOLOGY OF THE CELL | 2023年 / 34卷 / 02期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
SG237
引用
收藏
页码：162 / 162
页数：1
相关论文
共 50 条
  • [1] Biomarker-driven clinical trials for anti-cancer drug development
    Kim, Dong-Wan
    CANCER SCIENCE, 2023, 114 : 1703 - 1703
  • [2] PET in anti-cancer drug development and therapy
    Kumar, Rakesh
    Lal, Neena
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2007, 2 (03) : 259 - 263
  • [3] NEW APPROACH TO ANTI-CANCER DRUG DEVELOPMENT
    LANDES, RC
    BRITISH JOURNAL OF CANCER, 1975, 31 (02) : 254 - 254
  • [4] Molecular Modeling Applied to Anti-Cancer Drug Development
    Rosales-Hernandez, M. C.
    Bermudez-Lugo, J.
    Garcia, Jazmin
    Trujillo-Ferrara, J.
    Correa-Basurto, J.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2009, 9 (02) : 230 - 238
  • [5] Development of Fly Model for Anti-Cancer Drug Screen
    Bajpai, Anjali
    Khan, Sumbul Jawed
    Pal, Subhabrata
    Alam, Mohammad Atif
    Gupta, Ram Prakash
    Harsh, Sneh
    Mishra, Arati
    Patel, Poulam
    Sinha, Pradip
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2010, 62 (10) : 1436 - 1437
  • [6] Black patient representation in anti-cancer drug development
    Karol, Alexander B.
    Paredes, Rodrigo
    Fujiwara, Yu
    Argulian, Anna
    Joshi, Himanshu
    Galsky, Matt D.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [7] Editorial: Immunity in the development of anti-cancer drug resistance
    Meng, Ya
    Wang, Haitao
    Li, Xuebing
    Wu, Xinwei
    Sun, Heng
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [8] Development of a novel anti-cancer drug targeting for γ-glutamylcyclotransferase
    Ii, Hiromi
    Nakata, Susumu
    Taniguchi, Keiko
    Takagi, Hiroko
    Moyama, Chiami
    Kageyama, Susumu
    Yoshiki, Tatsuhiro
    CANCER SCIENCE, 2018, 109 : 1189 - 1189
  • [9] Ethnobotany and ethnopharmacy - Their role for anti-cancer drug development
    Heinrich, M
    Bremner, P
    CURRENT DRUG TARGETS, 2006, 7 (03) : 239 - 245
  • [10] Investigations on the development of biodegradable nanoparticles for anti-cancer drug
    Vandati, Seyed Goodarz Fallah
    BIOSCIENCE BIOTECHNOLOGY RESEARCH COMMUNICATIONS, 2019, 12 (01): : 36 - 45
12345